Analysts Set CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) PT at $117.00

Shares of CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) have been assigned a consensus rating of “Hold” from the six research firms that are currently covering the firm, MarketBeat reports. Five analysts have rated the stock with a hold recommendation and one has issued a strong buy recommendation on the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $117.00.

Several analysts recently commented on the company. Zacks Research upgraded CochLear from a “strong sell” rating to a “hold” rating in a report on Monday, June 22nd. Jefferies Financial Group lowered shares of CochLear from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 22nd. UBS Group downgraded shares of CochLear from a “strong-buy” rating to a “hold” rating in a research report on Thursday, April 23rd. Finally, Royal Bank Of Canada lowered shares of CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 price objective on the stock. in a research note on Thursday, July 16th.

CochLear Stock Performance

Shares of CHEOY opened at $41.90 on Wednesday. CochLear has a 1 year low of $31.82 and a 1 year high of $105.60. The business has a 50-day moving average of $38.98 and a 200-day moving average of $56.25.

CochLear Company Profile

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.